Auratus Bio LLC

Biotech · Private

Genetically engineered hamster models with STAT knockout for disease research

Grants
$441K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of a STAT2 knock-out hamster model for wild-type filovirus infections$220,647
Federal grantDepartment of Health and Human Services · Phase I · Development of a STAT2 knock-out hamster model for wild-type filovirus infections$220,647
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3276DIVINER THERAPEUTICS, LLC——
3277VIROGENOMICS BIODEVELOPMENT, INC.——
3278ENZERNA BIOSCIENCES LLC——
3279Auratus Bio LLC——
3280ASKO THERAPEUTICS, INC.——
3281UNITED BIOTHERAPEUTICS LLC——
3282TARGETSITE THERAPEUTICS CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.